Non-coding RNAs in the reprogramming of glucose metabolism in cancer - PubMed (original) (raw)

Review

. 2018 Apr 10:419:167-174.

doi: 10.1016/j.canlet.2018.01.048. Epub 2018 Jan 31.

Affiliations

Review

Non-coding RNAs in the reprogramming of glucose metabolism in cancer

Ram C Shankaraiah et al. Cancer Lett. 2018.

Abstract

Proliferating cancer cells reprogram their metabolic circuitry to thrive in an environment deficient in nutrients and oxygen. Cancer cells exhibit a higher rate of glucose metabolism than normal somatic cells, which is achieved by switching from oxidative phosphorylation to aerobic glycolysis to meet the energy and metabolites demands of tumour progression. This phenomenon, which is known as the Warburg effect, has generated renewed interest in the process of glucose metabolism reprogramming in cancer cells. Several regulatory pathways along with glycolytic enzymes are responsible for the emergence of glycolytic dependence. Non-coding (nc)RNAs are a class of functional RNA molecules that are not translated into proteins but regulate target gene expression. NcRNAs have been shown to be involved in various biological processes, including glucose metabolism. In this review, we describe the regulatory role of ncRNAs-specifically, microRNAs and long ncRNAs-in the glycolytic switch and propose that ncRNA-based therapeutics can be used to inhibit the process of glucose metabolism reprogramming in cancer cells.

Keywords: Aerobic glycolysis; Cancer glucose metabolism; Non-coding RNA; Warburg effect.

Copyright © 2018 Elsevier B.V. All rights reserved.

PubMed Disclaimer

Publication types

MeSH terms

Substances

LinkOut - more resources